ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 475

Adolescents’ Perspectives on Living with Childhood-Onset Systemic Lupus Erythematosus

Onengiya Harry1, Angela C Combs2, Brooke Hater2, Emily Roemisch2, Leslie A. Favier3, Najla Aljaberi4, Aimee W Smith2, Rhyanne McDade2, Lauren Fussner5, Jennifer L. Huggins6, Lori E Crosby2 and Avani C Modi7, 1Pediatric Rheumatology, Cincinnati Childrens' Hospital Medical Center, Cincinnati, OH, 2Behavior Medicine and Clinical Psychology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 3Pediatric Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 4Pediatric Rheumatology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, 5Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 6Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, 7Center for Treatment Adherence and Self-Management, Cincinnati Children's Hospital Medical Center, Cincinnati, OH

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: pediatric rheumatology and qualitative, SLE

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 21, 2018

Title: Pediatric Rheumatology – Clinical Poster I: Lupus, Sjögren’s Disease, and Myositis

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Non-adherence to medical recommendations in childhood-onset systematic lupus erythematosus (cSLE) is estimated to be between 40-50%. For patients with cSLE, non-adherence results in increased hospitalizations, preventable disease damage, disease flares, and higher health care costs. Currently there are no published data regarding adolescent patients’ perspectives on the management of cSLE, including barriers to treatment adherence. The aim of this study was to characterize the adolescent’s perspective on the management of cSLE and its impact on their lives. 

Methods: Ten adolescents diagnosed with cSLE per ACR SLE classification criteria were recruited from a pediatric rheumatology clinic and cSLE patient registry. Participants’ characteristics are summarized in Table 1. Two separate focus groups were conducted and led by trained facilitators to discuss topics around living with cSLE and its management. The sessions were audio-taped, transcribed, and coded for themes by three independent coders.

Results: Focus group transcript analyses revealed seven major themes: 1) Barriers/Facilitators of treatment adherence, 2) Symptoms Impacting Daily Life, 3) Lack of Understanding/Knowledge about cSLE, 4) Impact on personal relationships, 5) Self-care and management, 6) Worry about the Future, and (7) Relationship/communication with healthcare providers. Adherence barriers included the number, taste, timing and side effects of oral medications. Adherence facilitators were desire to avoid being sick/in pain/hospitalized, use of pill boxes, reminder apps, and storage location of pills. Fatigue, pain, and mood significantly impacted daily life for these adolescents. All adolescents described difficulties at school, including absenteeism related to disease flares and hospitalizations, missed school work, bullying, and/or the general lack of awareness and understanding of cSLE among educators and peers. They emphasized the role of healthcare providers in helping increase schools’ awareness and understanding of cSLE. Future worries were quality of life, transition to college, and job opportunities. All adolescents wanted direct communication with, and between, their providers.

Conclusion: While adherence was identified as a significant problem, some adolescents also noted strategies to improve self-management. All adolescents desired increased knowledge/understanding from the public regarding cSLE, especially aimed at school advocacy. Important next steps are to identify modifiable factors, with the long-term goal of developing interventions to improve the overall well-being and self-management for adolescents with cSLE.

Characteristic                                                                                          Adolescent                                      

                                                                                                                     (n = 10)                                             

Demographics

Female, No. (%)                                                                                        10 (100)                                             

Age, mean (SD), y                                                                                     16.1 (1.6)                                           

Race/Ethnicity, No. (%)                                                                                   

   White non-Hispanic                                                                                    7 (70)                                                 

   Black non-Hispanic                                                                                 3 (30)                                                 

   Other, non-Hispanic                                                                                 -                                                        

   Hispanic                                                                                                      -                                                           

cSLE characteristics

Disease duration, mean (SD), y                                                              2.7 (2.5)                                              

SLEDAI¥, mean (SD)                                                                                  4 (4.19)

Presence of lupus nephritis, No. (%)                                                     2 (20)                                                   

Comorbidities, No. (%)                                                                             7 (70)

Table 1: Participant demographical and disease characteristics

¥SLEDAI 2K score from clinic visit preceding focus group session. Range of scores is 0-14 for participants.

‡dyslipidemia, hypovitaminosis D, ADHD, anti-phospholipid abs.

 


Disclosure: O. Harry, None; A. C. Combs, None; B. Hater, None; E. Roemisch, None; L. A. Favier, None; N. Aljaberi, None; A. W. Smith, None; R. McDade, None; L. Fussner, None; J. L. Huggins, None; L. E. Crosby, None; A. C. Modi, None.

To cite this abstract in AMA style:

Harry O, Combs AC, Hater B, Roemisch E, Favier LA, Aljaberi N, Smith AW, McDade R, Fussner L, Huggins JL, Crosby LE, Modi AC. Adolescents’ Perspectives on Living with Childhood-Onset Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/adolescents-perspectives-on-living-with-childhood-onset-systemic-lupus-erythematosus/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/adolescents-perspectives-on-living-with-childhood-onset-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology